{"schema_version":"secwatch.filing_event.v1","accession":"0001860742-23-000026","form_type":"8-K","ticker":"BLCO","cik":"0001860742","company_name":"Bausch & Lomb Corp","filed_at":"2023-11-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:31.160466+00:00","generated_at":"2026-06-09T03:17:06.525891+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Bausch + Lomb Q3 revenue $1.007B, raises full-year 2023 revenue and EBITDA guidance","bullets":["Q3 revenue $1.007B (+7% YoY, +8% constant currency); GAAP net loss of $84M vs $18M loss prior year.","Adjusted EBITDA $187M (flat YoY); adjusted EPS $0.22 (vs $0.31 prior year).","Full-year 2023 revenue guidance raised to $4.035-$4.085B; Adjusted EBITDA guidance raised to $710-$760M.","Vision Care revenue rose 9% to $648M; Surgical up 8% to $185M; Pharmaceuticals flat at $174M.","Launched MIEBO for dry eye and acquired XIIDRA; distribution system upgrade impacted contact lens sales, expected to resolve in Q1 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001860742-23-000026","json":"https://secwatch.observer/filing/0001860742-23-000026.json","markdown":"https://secwatch.observer/filing/0001860742-23-000026.md","text":"https://secwatch.observer/filing/0001860742-23-000026.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1860742/000186074223000026/0001860742-23-000026-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1860742/000186074223000026/blco-20231101.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-09T03:17:06.525891+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"e1a68eecb5939a9f5b5045daf58e82923da2c383","claim":"Bausch & Lomb Corp reported the quarter ended September 30, 2023 results: revenue $1.007 billion, net income $84 million. Guidance raised.","evidence_excerpt":"to the Securities Act of 1933, as amended. --- EX-99.1 (EX-99.1) --- Bausch + Lomb Announces Third-Quarter 2023 Results and Raises Full-Year 2023 Guidance • Revenues of $1.007 Billion • GAAP Net Loss Attributable to Bausch + Lomb Corporation of $84 Million • Adjusted EBITDA (non-GAAP) 1 of $187 Million • Revenues Grew 7% as Reported and 8% on a Constant","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1860742/000186074223000026/0001860742-23-000026-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter ended September 30, 2023"},{"label":"Revenue","value":"$1.007 billion"},{"label":"Net income","value":"$84 million"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}